China Life Private Equity Investment
Overview
China Life Private Equity Investment is a professional private equity investment firm and a subsidiary of China Life Group, established in 2016. The firm focuses on long-term value investing, particularly in the healthcare and technology sectors, and manages the flagship China Life Healthcare Fund.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| hithium | Jun 2023 | Series C | Lead |
| Xi'an Eswin Material Technology Co., Ltd. | Dec 2022 | Series C | Co-investor |
| Cascade Pharmaceuticals, Inc. | Feb 2026 | Series C | Co-investor |
| GeneQuantum Healthcare | May 2021 | Series C | Lead |
| Jiangsu Vcare Pharmatech Co., Ltd. | Jan 2024 | Series C | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is China Life Private Equity Investment based?
China Life Private Equity Investment is headquartered in Shanghai, China.
When was China Life Private Equity Investment founded?
China Life Private Equity Investment was founded in 2016.
How many portfolio companies does China Life Private Equity Investment have?
China Life Private Equity Investment has 5 portfolio companies in Caplight's dataset.
What are some companies in China Life Private Equity Investment's portfolio?
Portfolio companies visible on Caplight include hithium, Xi'an Eswin Material Technology Co., Ltd., Cascade Pharmaceuticals, Inc., GeneQuantum Healthcare, Jiangsu Vcare Pharmatech Co., Ltd..
What was China Life Private Equity Investment's most recent investment shown here?
China Life Private Equity Investment's most recent investment in this portfolio sample was in Cascade Pharmaceuticals, Inc. in 2026.
What sectors does China Life Private Equity Investment focus on?
China Life Private Equity Investment focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech.
What company stages does China Life Private Equity Investment focus on?
China Life Private Equity Investment typically invests at the Mid stage.
What is China Life Private Equity Investment's AUM?
China Life Private Equity Investment's assets under management are estimated between $5.8B and $5.8B.